Testing effectiveness (Phase 2)Study completedNCT00427557What this trial is testingCellular Therapy With Cord Blood CellsWho this might be right forMultiple MyelomaLeukemiaLymphoma M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Ended earlyNCT01251965What this trial is testingPhase l/II Study of Ruxolitinib for Acute LeukemiaWho this might be right forLeukemia M.D. Anderson Cancer Center 27
Early research (Phase 1)Ended earlyNCT00005787What this trial is testingPeripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaNeutropenia Northwestern University 3
Not applicableUnknownNCT03390387What this trial is testingChildhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015)Who this might be right forChildhood Acute Lymphoblastic Leukemia Federal Research Institute of Pediatric Hematology, Oncology and Immunology 4,000
Early research (Phase 1)UnknownNCT02413021What this trial is testingThe Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy RegimensWho this might be right forAcute Myeloid LeukemiaAcute Lymphoid Leukemia Isfahan University of Medical Sciences 40
Early research (Phase 1)Study completedNCT00986804What this trial is testingDecitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post TransplantWho this might be right forLeukemia, Myeloid, AcuteMyelodysplastic Syndromes Washington University School of Medicine 24
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT04553692What this trial is testingPhase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersWho this might be right forSolid TumorColorectal CancerNon Hodgkin Lymphoma+5 more IGM Biosciences, Inc. 272
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07162571What this trial is testingThis is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.Who this might be right forAcute Lymphobkastic LeukemiaB Cell Lymphoma Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 17
Testing effectiveness (Phase 2)Study completedNCT00083187What this trial is testingVNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk MyelodysplasiaWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Vion Pharmaceuticals 230
Not applicableEnded earlyNCT02519712What this trial is testingTreatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related DonorsWho this might be right forAcute Myeloid Leukemia (AML) Memorial Sloan Kettering Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT00602771What this trial is testingTipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more National Cancer Institute (NCI) 84
Not applicableUnknownNCT02176109What this trial is testingMetabolism Des LAMWho this might be right forIronAcute Myeloid LeukemiaDiagnosis+1 more University Hospital, Grenoble 80
Not applicableWithdrawnNCT01688752What this trial is testingCardiometabolic Status in Childhood Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia University of Minnesota
Testing effectiveness (Phase 2)UnknownNCT05809167What this trial is testingVenetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCTWho this might be right forAllogeneic Hematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia The First Affiliated Hospital of Soochow University 55
Large-scale testing (Phase 3)Looking for participantsNCT05805098What this trial is testingVenetoclax Combined With Homoharringtonine and Cytarabine in Induction for AMLWho this might be right forAcute Myeloid Leukemia The First Affiliated Hospital of Soochow University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06456463What this trial is testingTagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive ChemotherapyWho this might be right forAcute Myeloid Leukemia Stemline Therapeutics, Inc. 83
Testing effectiveness (Phase 2)Study completedNCT00763763What this trial is testingImatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL PositiveWho this might be right forLeukemia, Lymphocytic, AcutePhiladelphia ChromosomeBlast Crisis+1 more Assistance Publique - Hôpitaux de Paris 55
Early research (Phase 1)Looking for participantsNCT03326921What this trial is testingHA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell TransplantWho this might be right forJuvenile Myelomonocytic LeukemiaRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Undifferentiated Leukemia+26 more Fred Hutchinson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00003840What this trial is testingDTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid LeukemiaWho this might be right forLeukemia Wake Forest University Health Sciences